09 December 2012

UK SURGEON OVERTON suggested FINGERPRINTS 50 years before police took notice.



From UK DAILY MAIL

The notorious killer Jack the Ripper might have been caught if police had paid attention to a doctor's theory about using fingerprints to solve crimes, it emerged today.
But the authorities ignored the suggestion of the village surgeon and it was another 50 years before forensic evidence was used for identification purposes.
His three-page letter written in 1840 detailing how fingerprints could track down murderers is being auctioned at Sothebys this week.
Horror: A cartoon of the grisly discovery by police of one of Jack The Ripper's female victims
Horror: A cartoon of the grisly discovery by police of one of Jack The Ripper's female victims
The note refers to the shocking killing on May 6, 1840, of 73-year-old  politician Lord William Russell who was found in his bed with his throat cut at his Mayfair townhouse.
 
Ten days later, surgeon Robert Blake Overton, who lived in  the Norfolk village of Grimstone, wrote to the victim's nephew, Lord John Russell - the future prime minister - who passed it onto Scotland Yard.
The letter: Surgeon Robert Bllake Overton even used two inky fingerprints to illustrate his theory
The letter: Surgeon Robert Blake Overton even used two inky fingerprints to illustrate his theory
In it, he referred to the marks of 'bloody fingers' found at the scene, adding: 'It is not generally known that every individual has a peculiar arrangement [on] the grain of the skin …
'I would strongly recommend the propriety of obtaining impressions from the fingers of the suspected individual and a comparison made with the marks on the sheets and pillows.'
Overton explained that “the impressions made from the fingers of different persons will produce different shapes.'
The doctor even included two pairs of inky fingerprints in his letter to illustrate his theory.
The letter - among some 700 original documents relating to the murder investigation and later trial are owned by the Law Society. The collection is expected to fetch £6,000.
Dr Gabriel Heaton, the auctioneer's manuscript specialist, told the Independent:: 'If this idea had been taken up, the whole criminal history of the Victorian period – of the foggy streets and of Sherlock Holmes and of Jack the Ripper – would have looked very different.

'This obscure village surgeon was suggesting the forensic use of fingerprint evidence  a full 50 years before the procedure was adopted.'
It wasn't until the late 1850s that William Hershel, a British officer, used fingerprints for identification  on contracts in India. 
And it was not until the 1890s that pioneering use was made of fingerprints in criminal investigations. Even Sherlock Holmes did not use fingerprints until 1903.

Fingerprint
Caricature of the Ripper
Clue: A fingerprint and caricature of Jack The Ripper the unidentified serial killer of vice girls in Whitechapel
Mr Heaton added: 'Perhaps even Jack the Ripper might have been caught. Instead, this letter was filed away and Overton himself disappears from the history of forensics.'
But fingerprint evidence would not have helped to solve Russell's murder. Scotland Yard took up Overton's suggestion but recorded on the back of the letter that, 'there were no such marks except those made by the Surgeons who first examined the wound.'
Russell's Swiss valet, François Benjamin Courvoisier, was later charged and confessed. His execution was attended by thousands,

SWISS MEDICAL WEEKLY


Inbox


 




Read the Journal Submit to SMW Get E-Mail Alerts Contact Us Website EMH
SMW newsletter, 07 December 2012 email: office@smw.ch


Recently published articles on www.smw.ch
Sündermann SH, Falk V, Jacobs S
Review article: Current opinion, published 28 November 2012

Burkhalter F, Steiger J, Dickenmann M
Review article: Current opinion, published 28 November 2012

Dean Y, Dépis F, Kosco-Vilbois M
Review article, published 28 November 2012

Rod Fleury T, Favrat B, Belaieff W, Hoffmeyer P
Review article, published 27 November 2012

Ott R, Lenk C, Miller N, Neuhaus Bühler R, Biller-Andorno N
Original article, published 27 November 2012

Guessous I, Dudler V, Glatz N, Theler JM, Zoller O, Paccaud F, Burnier M, Bochud M
Original article, published 26 November 2012

Utzinger J, Becker SL, Knopp S, Blum J, Neumayr AL, Keiser J, Hatz CF
Review article: Current opinion, published 22 November 2012

Heuss L, Sugandha SP, Degen L
Short communication, published 05 November 2012

Berdajs D, Marinakis S, Kessler U, Muradbegovic M, Ferrari E, von Segesser LK
Original article, published 05 November 2012

van Berlo D, Clift MJD, Albrecht C, Schins RPF
Review article: Current opinion, published 05 November 2012

Chmiel C, Wang M, Senn O, Del Prete V, Zoller M, Rosemann T, Steurer-Stey C
Original article, published 30 October 2012

Darling KEA, Niederhauser J, Bervini D, Giulieri S, Daniel RT, Bille J, Erard V
Peer reviewed letter, published 29 October 2012

Bernhard S, Spaniol V, Aebi C
Review article: Current opinion, published 29 October 2012

Murer M, Schmied C, Battegay E, Keller DI
Original article, published 25 October 2012

Fahrner R, Ochsenbein A, Schmid RA, Carboni GL
Original article, published 25 October 2012

Bauer M, Caviezel S, Teynor A, Erbel R, Mahabadi AA, Schmidt-Trucksäss A
Review article, published 25 October 2012

Bellut D, Hlavica M, Muroi C, Woernle CM, Schmid C, Bernays RL
Original article, published 23 October 2012

Nendaz M, Perrier A
Review article: Current opinion, published 23 October 2012

Carrel T, Englberger L, Martinelli MV, Takala J, Boesch C, Sigurdadottir V, Gygax E, Kadner A, Mohacsi P
Review article: Current opinion, published 18 October 2012

IceCure Medical : Caesarea & Cleveland.

quoted in today's UK DAILY MAIL


IceCure Medical, Inc.wirby@icecure-medical.com

ISRAEL’S ICECURE MEDICAL OPENS U.S. HEADQUARTERS IN CLEVELAND
CAESAREA, ISRAEL and CLEVELAND, OH – IceCure Medical LTD., an Israeli medical device company providing physicians with minimally-invasive, office-based, cryoablation solutions for women’s health, will open its U.S. headquarters on June 1, 2011 in Cleveland’s Global Cardiovascular Innovation Center (GCIC).
"The unique infrastructure for growing biomedical companies, the support we received from many
organizations, and the progressive health care environment that includes world-class institutions such as the
Cleveland Clinic and University Hospitals Case Medical Center, led us to choose Cleveland for our US
operations,” said Hezi Himelfarb, CEO of IceCure Medical.
The IceCure Cleveland-based staff will be launching U.S. marketing and sales of the new state-of-the-art
IceSense3™ cryoablation system. The IceSense3 technology treats benign breast growths through freezing, as a quick, safe and successful alternative to invasive surgery. “We are thrilled to offer a patient-friendly, inoffice, minimally invasive treatment for benign breast disease,” said Mr. Himelfarb.

“We are pleased that IceCure has selected Ohio as the location for its US operations," said Jim Leftwich, the
Director of the Ohio Department of Development. "The State of Ohio has strongly supported the development
of a vibrant biomedical innovation environment."
“The Health Tech Corridor builds on one of our region's economic strengths and is an international destination
for medical technology companies. Cleveland’s ability to attract companies like IceCure and help them develop
their business is essential for the growth and success of the area,” said Mayor Frank G. Jackson. “We welcome
them home to the City of Cleveland.”
“This is a testament to how well Northeast Ohio’s economic development partners work together to attract
leading organizations into our growing biomedical cluster,” said Tom Waltermire, CEO of Team Northeast
Ohio (NEO). “In the future, we anticipate that IceCure Medical will bring 15 highly skilled jobs and roughly $1
million in annual payroll into the Cleveland Plus region.”
“IceCure Medical has strong growth potential,” said Baiju R. Shah, president and CEO of BioEnterprise, “It's a
testament to the state’s and region’s initiatives to attract foreign high-tech firms and support their business
growth in the U.S, including Israeli companies such as MDG Medical, NI Medical, and Simbionix, that IceCure
has selected Cleveland.”
Supported by the Ohio Capital Fund, Bridge Investment Fund LP has been instrumental in supporting Israeli
companies with innovative technology set up operations in Cleveland. “Bridge works closely with its portfolio
companies to address their specific needs to grow in the US market, and we look forward to IceCure opening
shop here,” said Michael Goldberg, managing director of the Fund.
IceCure Medical will lease space in GCIC’s 50,000 sq. ft. facility adjacent to the Cleveland Clinic, which
“provides close proximity to world-class clinical researchers and clinicians along with extensive facility and
business support services,” according to GCIC Managing Director, Mark Low.
About IceCure Medical Ltd
IceCure Medical Ltd. Is a publicly traded medical device company (TASE: ICCM), focusing on minimally
invasive, office-based, cryoablation solutions for treating women’s tumors. The company was founded in 2006
with main offices in Caesarea, Israel and U.S. headquarters in Cleveland, Ohio. For more information, visit:
www.icecure-medical.com.